首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Journal of market access health policy

缩写:

ISSN:2001-6689

e-ISSN:

IF/分区:0.0/

文章目录 更多期刊信息

共收录本刊相关文章索引352
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Jesper Jørgensen,Panos Kefalas Jesper Jørgensen
Background: Outcomes-based reimbursement (OBR) can reduce decision uncertainty and accelerate patient access to cell and gene therapies, however, OBR is rarely applied in practice in England. Oncology is the therapy area with the most cell ...
Emilie Clay,Olivier Cristeau,Romain Chafaie et al. Emilie Clay et al.
Objective: To update the health economic evaluation of pirfenidone in the treatment of idiopathic pulmonary fibrosis (IPF) compared to all available alternatives strategies (Best supportive care - BSC and nintedanib), based on a cost-utilit...
[This corrects the article DOI: 10.1080/20016689.2019.1618661.].
Nicola Germain,Samuel Aballéa,Mondher Toumi Nicola Germain
The importance of understanding the impact of disease and treatment on children's Health-Related Quality of Life (HRQoL) has given rise to an increasing use of child self-report and observer or proxy instruments. In this article, we review ...
Jacques Savary,Marie Christelle Tine,Anne Caroline Weber et al. Jacques Savary et al.
Background: Actinic keratosis (AK) is characterized by the occurrence of thick and scaly skin areas caused by damage from ultraviolet radiation. The management of AK aims to reduce lesions and prevent their recurrence by regular monitoring....
Daniel C Malone,Rebecca Dean,Ramesh Arjunji et al. Daniel C Malone et al.
Background: Spinal muscular atrophy type 1 (SMA1) is a devastating genetic disease for which gene-replacement therapy may bring substantial survival and quality of life benefits. Objective: This study investigated the cost-effectiveness of ...
Claudia Eder,Claudia Wild Claudia Eder
Background: The umbrella term ATMPs (Advanced Therapy Medicinal Products) comprises cell therapies, gene therapeutics and tissue engineered products. After implementation of the Regulation 1394/2007, only a couple of products have obtained ...
Katia Thokagevistk,Clément François,Mélanie Brignone et al. Katia Thokagevistk et al.
Background: The relative efficacy and safety can vary among drugs over time. Sumatriptan, a first choice drug for acute migraine, can illustrate this phenomenon. Objective: To assess the evolution of the relative efficacy and tolerability o...
Naina R Verghese,Jon Barrenetxea,Yukti Bhargava et al. Naina R Verghese et al.
Background and objectives: Governments in Asia Pacific (APAC) are increasingly using pharmaceutical pricing strategies to contain rising healthcare costs. The objective of this narrative review is to discuss formal pricing strategies for re...
Małgorzata Biernikiewicz,Vanessa Taieb,Mondher Toumi Małgorzata Biernikiewicz
Objective: Doctor-shopping has significant consequences for patients and payers and can indicate misuse of drugs, polypharmacy, less continuity of care, and increased medical expenses. This study reviewed the literature describing doctor-sh...